In recent years, new psychoactive substances (NPS) have flooded the recreational drug market. The two largest groups monitored by the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) are the synthetic cannabinoids and the cathinones [1]. Other than these two groups, there is a broad range of various other compounds such as new benzodiazepines, tryptamines, phenethylamines and opioids. Most recently, synthetic opioids have appeared on the drug market, including fentanyl derivatives and other opioid agonists such as AH-7921 and MT-45 which are described in the present cases.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oIuTge
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background. Reconstruction of surgical defects following cranial base surgery is challenging. Others have demonstrated that leukocyte-platel...
-
During lytic infection, herpes simplex virus (HSV) DNA is replicated by a mechanism involving DNA recombination. For instance, replication o...
-
Outcomes of multimodal management for sinonasal squamous cell carcinoma. J Craniomaxillofac Surg. 2017 May 12;: Authors: Paré A, Blan...
-
Abstract Purpose Low back pain is a significant problem for school-aged athletes. Although some risk factors relating to sports activiti...
-
Thyroid cancer is the most common malignant tumor of the endocrine system and the incidence has been increasing in recent years. In a great ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου